Metronidazole and Misonidazole in Cancer Chemotherapy: Effect of Cell Density on Drug Activity

  • J. S. Mahood
  • R. L. Willson
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 42)


Metronidazole (Flagyl) has been widely used for many years for the treatment of infections by anaerobic microorganisms (1).


Cancer Chemotherapy High Cell Density Serratia Marcescens Hypoxic Cell Sodium Lactate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E. J. Baines, Metronidazole: sixteen years of developments: metronidazole, in: Excerpta Medica, S. M. Finegold ed. p.61, and refs cited (1977).Google Scholar
  2. 2.
    J. L. Foster and R. L. Willson, Radiosensitization of anoxic cells by metronidazole, Br. J. Radiol., 46:234 (1973).PubMedCrossRefGoogle Scholar
  3. 3.
    P. T. Emmerson and P. Howard Flanders, Sensitization of anoxic bacteria to X-rays by organic nitroxide free radicals, Radiat. Res., 26: 54 (1965).PubMedCrossRefGoogle Scholar
  4. 4.
    G. E. Adams and D. L. Dewey, Hydrated electrons and radiobiological sensitization, Biochem. Biophys. Res. Comm., 12: 473 (1963).CrossRefGoogle Scholar
  5. 5.
    R. L. Willson and P. T. Emmerson, Reaction of triacetone-anine-N-oxyl with radiation-induced radicals from DNA and from deoxyribonucleotides in aqueous solution, in: “Radioprotection and Sensitization”, H. L. Moroson and M. Quintilian ed., Taylor and Francis Ltd., London (1970).Google Scholar
  6. 6.
    H. N. Prince, E. Grunberg, E. Titsworth and W. F. Delorenzo, Effects of 1-(2-nitro-l-imidazole)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa, Applied Microbiol., 18: 728 (1969).Google Scholar
  7. 7.
    J. C. Asquith, J. L. Foster and R. L. Willson, Metronidazole (Flagyl). A radiosensitizer of hypoxic cells, Br. J. Radiology, 47: 474 (1974).CrossRefGoogle Scholar
  8. 8.
    A. C. Begg, P. W. Sheldon and J. L. Foster, Demonstration of hypoxic cells in solid tumours by metronidazole, Br. J. Radiol. 47: 399 (1974).PubMedCrossRefGoogle Scholar
  9. 9.
    R. M. Sutherland, Selective chemotherapy of non-cycling cells in an in vitro tumour model, Cancer Res., 34: 3501 (1974).PubMedGoogle Scholar
  10. 10.
    J. L. Foster and R. L. Willson, Metronidazole (Flagyl) in cancer radiotherapy, Chemotherapy, 7: 215 (1976).CrossRefGoogle Scholar
  11. 11.
    J. L. Foster, P. J. Conroy, A. J. Searle and R. L. Willson, Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells. Br. J. Cancer, 33: 485 (1976).PubMedCrossRefGoogle Scholar
  12. 12.
    J. K. Mohindra and A. M. Rauth, Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells, Cancer Res., 36: 930 (1976).PubMedGoogle Scholar
  13. 13.
    R. Sridhar, C. Koch and R. Sutherland, Cytotoxicity of two nitroimidazole radiosensitizers in an in vitro tumour model. Int. J. Radiat. Oncol. Biol. Phys., 1: 1149 (1976).Google Scholar
  14. 14.
    J. L. Foster, Differential cytotoxic effects of metronidazole and other nitro heterocyclic drugs against hypoxic tumour cells, Int. J. Radiat. Oncol. Biol. Phys., 2:Suppl.Ill: 153 (1977).Google Scholar
  15. 15.
    E. J. Hall, M. Astor, C. Geard and J. Biaglow, Cytotoxicity of Ro-07-0582: enhancement by hyperthermia and protection by cysteamine, Br. J. Cancer, 35: 809 (1977).PubMedCrossRefGoogle Scholar
  16. 16.
    E. J. Hall, R. Miller, M. Astor and F. Rini, The nitroimidazoles as radiosensitizers and cytotoxic agents. Br. J. Cancer, 37:Suppl.Ill: 120 (1978).Google Scholar
  17. 17.
    Y. C. Taylor and A. M. Rauth, Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. Cancer Res., 38: 2745 (1978).PubMedGoogle Scholar
  18. 18.
    S. H. Basaga, J. R. Dunlop, A. J. F. Searle and R. L. Willson, Metronidazole (Flagyl) and Misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo. Br. J. Cancer, 37:Suppl.Ill: 132 (1978).Google Scholar
  19. 19.
    I. J. Stratford, Split dose cytotoxic experiments with misonidazole. Br. J. Cancer, 38: 130 (1978).PubMedCrossRefGoogle Scholar
  20. 20.
    E. 0. Pettersen, Toxic and radiosensitizing effect of the 2-nitroimidazole Misonidazole (Ro-07-0582) on murine CFU in vivo. Br. J. Cancer 37:Suppl.Ill: 107 (1978).Google Scholar
  21. 21.
    G. E. Adams, I. J. Stratford, R. G. Wallace, P. Wardman and M. E. Watts, Toxicity of nitrocompounds towards hypoxic mammalian cells in vitro: dependence on reduction potential. J. Nat. Cancer Inst., 64: 555 (1980).PubMedGoogle Scholar
  22. 22.
    D. W. Whillans and A. M. Rauth, An analysis of changes in oxygen tension in stirred cellular suspensions under con-ditions of radiolytic and cellular consumption. Cancer Clin. Trials, 3: 63 (1980).Google Scholar
  23. 23.
    B. H. J. Bielski and P. C. Chan, Kinetic study by pulse radiolysis of the lactate dehydrogenase-catalyzed chain oxidation of nicotinamide adenine dinucleotide by H02 and 07 radicals. J. Biol. Chem., 250: 318 (1974).Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • J. S. Mahood
    • 1
  • R. L. Willson
    • 1
  1. 1.Biochemistry DepartmentBrunel UniversityUxbridge, MiddlesexUK

Personalised recommendations